Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China

Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 125; no. 24; pp. 4460 - 4465
Main Authors Zhou, Li, Cao, Ya-li, Li, Wen-ge, Fu, Fang-ting, Zhang, Ling, Wang, Xiang, Shi, Xiao-hu
Format Journal Article
LanguageEnglish
Published China Department of Blood Purification, China-Japan Friendship Hospital, Beijing 100029, China%Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China%Department of Urology , China-Japan Friendship Hospital, Beijing 100029, China 20.12.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011. Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%), breast cancer (6%), lung cancer (4%), thyroid cancer (2%), and hematologic cancer (2%). Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease. Death occurred in eight patients out of 49, and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120). Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China.
Bibliography:Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011. Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%), breast cancer (6%), lung cancer (4%), thyroid cancer (2%), and hematologic cancer (2%). Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease. Death occurred in eight patients out of 49, and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120). Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China.
aristolochic acid nephropathy; end stage renal disease; hemodialysis; transitional cell carcinoma; urinary tract
11-2154/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0366-6999
2542-5641
2542-5641
DOI:10.3760/cma.j.issn.0366-6999.2012.24.025